Intracrine Testosterone Activation in Human Pancreatic Beta-Cells Stimulates Insulin Secretion

    August 2020 in “ Diabetes
    Weiwei Xu, Lina Schiffer, M.M. Fahd Qadir, Yan-Qing Zhang, James P. Hawley, Paula Mota de Sa, Brian G. Keevil, Hongju Wu, Wiebke Arlt, Franck Mauvais-Jarvis
    New to Estradiol? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary This study found that testosterone enhances insulin secretion in human pancreatic islets by being converted into DHT and E2, processes that are necessary for this effect.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study found that human pancreatic β-cells express enzymes that convert testosterone (T) to dihydrotestosterone (DHT) and estradiol (E2), which are necessary for the enhancement of glucose-stimulated insulin secretion (GSIS). The conversion of T to DHT and E2 was shown to be inhibited by 5α-reductase and aromatase inhibitors, respectively. The research suggests that these inhibitors could affect GSIS and potentially predispose older men to type 2 diabetes, while in women with androgen excess, intracrine androgen activation may contribute to β-cell dysfunction. The study concludes that β-cells in human pancreatic islets can locally activate sex steroids from circulating testosterone, which is crucial for their role in insulin secretion.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results